Yadav, V.; Mai, Y.; McCoubrey, L.E.; Wada, Y.; Tomioka, M.; Kawata, S.; Charde, S.; Basit, A.W.
5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines 2021, 9, 578.
https://doi.org/10.3390/biomedicines9050578
AMA Style
Yadav V, Mai Y, McCoubrey LE, Wada Y, Tomioka M, Kawata S, Charde S, Basit AW.
5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines. 2021; 9(5):578.
https://doi.org/10.3390/biomedicines9050578
Chicago/Turabian Style
Yadav, Vipul, Yang Mai, Laura E. McCoubrey, Yasufumi Wada, Motoyasu Tomioka, Satofumi Kawata, Shrikant Charde, and Abdul W. Basit.
2021. "5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease" Biomedicines 9, no. 5: 578.
https://doi.org/10.3390/biomedicines9050578
APA Style
Yadav, V., Mai, Y., McCoubrey, L. E., Wada, Y., Tomioka, M., Kawata, S., Charde, S., & Basit, A. W.
(2021). 5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines, 9(5), 578.
https://doi.org/10.3390/biomedicines9050578